title: Novel medical approaches for the treatment of Cushing's disease.
authors.affiliation: Department of Medicine, Cedars-Sinai Research Institute, David Geffen School of Medicine at UCLA, Los Angeles, USA. HeaneyA@csmc.edu
authors.forename: A P
authors.initials: AP
authors.lastname: Heaney
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002839:Chromans / Q000627:therapeutic use; D006801:Humans; D008024:Ligands; D047495:PPAR gamma / Q000187:drug effects / Q000502:physiology*; D047748:Pituitary ACTH Hypersecretion / Q000188:drug therapy*; D018168:Receptors, Retinoic Acid / Q000187:drug effects / Q000502:physiology; D045162:Thiazolidinediones / Q000627:therapeutic use; D014212:Tretinoin / Q000627:therapeutic use*; D000077288:Troglitazone
chemical_list: D000970:Antineoplastic Agents; D002839:Chromans; D008024:Ligands; D047495:PPAR gamma; D018168:Receptors, Retinoic Acid; D045162:Thiazolidinediones; D014212:Tretinoin; D000077288:Troglitazone
references.citation: Neurosurgery. 2001 Aug;49(2):284-91; discussion 291-2
references.pmid: 11504104
references.citation: Clin Endocrinol (Oxf). 1991 Jan;34(1):63-9
references.pmid: 2004474
references.citation: Diabetes. 1996 Dec;45(12):1661-9
references.pmid: 8922349
references.citation: J Clin Endocrinol Metab. 1998 Oct;83(10):3542-4
references.pmid: 9768661
references.citation: Curr Opin Oncol. 1999 Nov;11(6):497-502
references.pmid: 10550014
references.citation: Nature. 1990 Oct 18;347(6294):645-50
references.pmid: 2129546
references.citation: J Clin Endocrinol Metab. 1986 Sep;63(3):639-43
references.pmid: 3734034
references.citation: J Clin Endocrinol Metab. 1985 Sep;61(3):536-40
references.pmid: 2991327
references.citation: Nat Med. 1998 Sep;4(9):1046-52
references.pmid: 9734398
references.citation: J Endocrinol Invest. 1999 Dec;22(11):860-5
references.pmid: 10710275
references.citation: J Clin Endocrinol Metab. 1999 Nov;84(11):3859-66
references.pmid: 10566620
references.citation: Ann Intern Med. 1988 Sep 15;109(6):487-93
references.pmid: 2843068
references.citation: J Clin Invest. 2001 Oct;108(8):1123-31
references.pmid: 11602619
references.citation: Neuro Oncol. 2001 Jul;3(3):141-51
references.pmid: 11465394
references.citation: Lancet. 1987 Mar 7;1(8532):573
references.pmid: 2881126
references.citation: J Clin Endocrinol Metab. 1985 Oct;61(4):718-22
references.pmid: 4031015
references.citation: Nat Med. 2002 Nov;8(11):1281-7
references.pmid: 12379847
references.citation: Ann N Y Acad Sci. 2002 Sep;970:119-33
references.pmid: 12381547
references.citation: J Clin Endocrinol Metab. 2000 Feb;85(2):526-9
references.pmid: 10690849
references.citation: Nature. 1998 Jan 1;391(6662):79-82
references.pmid: 9422508
references.citation: Int J Epidemiol. 2000 Apr;29(2):197-207
references.pmid: 10817114
references.citation: Pituitary. 2002;5(2):77-82
references.pmid: 12675504
references.citation: Diabetes. 1998 Apr;47(4):507-14
references.pmid: 9568680
references.citation: Clin Endocrinol (Oxf). 1991 Aug;35(2):169-78
references.pmid: 1657460
references.citation: Clin Endocrinol (Oxf). 1987 Oct;27(4):461-7
references.pmid: 2830063
references.citation: Nature. 1992 Aug 27;358(6389):771-4
references.pmid: 1324435
references.citation: J Neurosurg. 2001 Jul;95(1):1-8
references.pmid: 11453376